NCT06505837 2025-08-28
JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer(NSCLC)
Shanghai Junshi Bioscience Co., Ltd.
Phase 3 Active not recruiting
Shanghai Junshi Bioscience Co., Ltd.
Jules Bordet Institute
Cancer Research Antwerp
The First Affiliated Hospital with Nanjing Medical University
Assiut University